Skip to main content

Sarai Garriga Edo

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Sarai Garriga Edo

Institutions of which they are part

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Marco Inzitari

Marco Inzitari

Head of group
Research on Aging, Frailty and Transitions in Barcelona
Read more
Georgina Arrambide García

Georgina Arrambide García

Main researcher
Clinical Neuroimmunology
Read more
Nicolas Garcia Rodriguez

Nicolas Garcia Rodriguez

Predoctoral researcher
Neurovascular Diseases
Read more
antonieta  falco

antonieta falco

Research Group of Physical Medicine and Rehabilitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.